Clinical Trial Update: Clinical Trial Phase III to Assess the Non-inferiority of Dalap Duo® Product Compared to Epiduo® in the Treatment of Acne Vulgaris [Phase 3]

View source ↗

Summary

A Phase III trial evaluating the non-inferiority of Dalap Duo compared with Epiduo for acne vulgaris has been withdrawn. The sponsor listed is Ache Laboratorios…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• Dalap Duo
• EPIDUO (adapalene and benzoyl peroxide)

Snippet

Sponsor: Ache Laboratorios Farmaceuticos S.A. | Conditions: Acne Vulgaris | Phase 3 | Status: WITHDRAWN